Improvement Seen in Survival With Adjuvant Pembrolizumab in Kidney Cancer
Disease-free survival benefit was consistent with that seen in previous analyses; improvement in overall survival also seen
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.